The central noradrenergic system: An overview

African Journal of Psychiatry (South Africa)

Volumn 10, Issue 3, 2007, Pages 135-141

  Viljoen, M ^a   Panzer, A ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Brainstern; Central noradrenergic system; Neuromodulatory

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; HISTAMINE; NORADRENALIN; SEROTONIN;

AGGRESSION; ALCOHOLISM; ALZHEIMER DISEASE; ANXIETY DISORDER; AROUSAL; ATTENTION DEFICIT DISORDER; BORDERLINE STATE; BRAIN FUNCTION; BRAIN STEM; CHOLINERGIC SYSTEM; COGNITION; CORTICOTROPIN RELEASE; DEPRESSION; DOPAMINE RELEASE; EATING DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; IMPULSE CONTROL DISORDER; MENTAL DISEASE; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PANIC; PATHOLOGICAL GAMBLING; PHOBIA; RETICULAR FORMATION; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TYPE A BEHAVIOR;

EID: 69949096817     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: 10.4314/ajpsy.v10i3.30245     Document Type: Review

References (103)

1. Windhorst U. Bilateral organisation of the brain. In: Gregor R, Windhorst U, eds, Comprehensive Human Physiology, Vol 1. Berlin: Springer-Verlag; 1996:1137-1160.
2. Jones BE. Arousal systems. Frontiers Biosci 2003;8:438-451.
3. Nolte N. Organization of the brainstem. In: The Human Brain. An introduction to its functional anatomy. St Louis Missouri: Mosby Inc, 1999:254-282.
4. Bear M, Connors BW, Paradiso MA. Neuroscience: Exploring the brain. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2001.
5. Grant SJ, Huang YH, Redmond DE. Benzodiazepines attenuate single unit activity in the locus coeruleus. Life Sci 1980;27:2231.
6. Aston-Jones G. Behavioural functions of locus coeruleus derived from cellular attributes. Physiol Psychol 1986;13:118-126.
7. Aston-Jones G, Shipley MT, Chovet G, Ennis M, van Bockstaele E, Pieribone V, Shiekhatter R. Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. Prog Brain Res 1991;88:47-75.
8. Lambert GW. Paring down on Descartes: a review of brain noradrenaline and sympathetic nervous function. Clin Exp Pharmacol Physiol 2001;28(12):979-982.
9. Esler MD, Lambert GW, Ferrier C, Kaye DM,Wallin BG, Kalff V, et al. Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertension 1995;17(1-2):409-423.
10. Holets VR: Anatomy and function of noradrenaline in the mammalian brain. In: The Pharmacology of Noradrenaline in the Central Nervous System. Oxford: University Press; 1990:1-27.
11. Svensson TH. Brain noradrenaline and the mechanisms of action of antidepressant drugs. Acta Psych Scand Suppl, 2000;402:18-27.
12. Srinivasan J, Schmidt WJ. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats. J Neural Transmiss 2004;111(1):13-26.
13. Feldman S,Weidenfeld J. Involvement of endogenous glutamate in the stimulatory effect of norepinephrine and serotonin on the hypothalamo-pituitary-adrenocortical axis. Neuroendocrinology 2004;79(1):43-53.
14. Stevens DR, Kuramasu A, Erikson KS, Selbach O, Haas HL. Alpha 2adrenergic receptor-mediated presynaptic inhibition of GABAergic IPSPs in rat histaminergic neurons. Neuropharmacology 2004;46(7):1018-1022.
15. Stone EA, Lin Y, Ahsan R, Quartermain D. Gross mapping of alpha 1-adrenoceptors that regulate behavioural activation in the mouse brain. Behav Brain Res 2004;152(2):167-175.
16. Geschwind N, Behan PO. Left-handedness: Association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci USA 1982;79:5097-5100.
17. Geschwind N, Galaburda AM. Cerebral lateralization: Biological mechanisms, associations, and pathology. Cambridge, MIT Press, 1987.
18. Chrousos GP, Gold PW. The concept of stress and stress systems disorders. JAMA 1992:267:1244-1252.
19. Dunn AJ, Swiergiel AH, Palamourchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann NY Acad Sci 2004;1018:25-34.
20. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety 2000;12(suppl 1):2-19.
21. Jobe PC. Common pathogenic mechanisms between depression and epilepsy: an experimental perspective. Epilepsy & Behav 2003;4(suppl 3):S14-S24.
22. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev 2004;45(1):38-78.
23. Leon M. Catecholaminergic contributions to early learning. Adv Pharmacol 1998;42:961-964.
24. Huether G. The central adaptation syndrome: Psychosocial stress as a trigger for adaptive modifications of brain structure and brain function. Prog Neurobiol 1996;48:569-612.
25. Arnsten AF, Steere JC, Jentsch DJ, Li BM. Noradrenergic influences on prefrontal cortical cognitive function: Opposing actions at postjunctional alpha 1 versus alpha 2 adrenergic receptors. Adv Pharmacol 1998; 42:764-767.
26. Partonen T. Possible pathophysiological mechanisms regulating food intake in seasonal affective disorder. Med Hypotheses 1996; 47(3):215-216.
27. Huang QH, Takaki A, Arimura A. Central noradrenergic system modulates plasma interleukin-6 production by peripheral interleukin-1. Am J Physiol 1997;273:R731-738.
28. Witte EA, Marrocco RT. Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of overt orientating. Psychopharmacol 1997;132(4):315-323.
29. Dratman MB, Gordon JT. Thyroid hormones as neurotransmitters. Thyroid 1996;6(6):639-647.
30. Arnsten AF, Steere JC, Hunt RD. The contribution of alpha 2noradrenergic mechanisms of prefrontal cortical significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996;53(5):448-455.
31. Berridge CW. Modulation of forebrain electroencephalographic activity and behavioural state by the locus coeruleus - noradrenergic system: Involvement of the medial septal area. Adv Pharmacol 1988;42:744-748.
32. Hasselmo ME, Linster C, Patil M, Cekic M. Noradrenergic suppression of synaptic transmission may influence cortical signalto- noise ratio. J Neurophysiol 1997;77(6):3326-3339.
33. Katsuki H, Izumi Y, Zorumski CF. Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region. J Neurophysiol 1997;77(6):3013-20.
34. Michaloudi HC, Mjboudi M, Poulain DA, Papadopoulos GC, Theodosis DT. The noradrenergic innervation of identified hypothalamic magnocellular somata and its contribution to lactation-induced synaptic plasticity. J Neuroendocrinol 1997;9(1):17-23.
35. Rorig B, Sutor B. Regulation of gap junction coupling in the developing neocortex. Mol Neurobiol 1996;2(3):225-249.
36. Bhatia SC, Saha S, Manchanda SK, Nayar U. Role of midbrain ventro-lateral tegmental area (VLTA) adrenergic mechanisms in facilitation of hypothalamically-induced predatory attack behaviour. Indian J Exp Biol 1997;35(4):332-337.
37. Bremner JD, Krystal JH, Southwick SM, Charney D. Noradrenergic mechanisms in stress and anxiety. I Preclinical studies. Synapse 1996;23:28-38.
38. Bremner JD,Krystal JH, Southwick, Charney DS. Noradrenergic mechanisms in stress and anxiety. II. Clinical Studies. Synapse 1996;23:39-51.
39. Cirelli C, Tononi G. Locus coeruleus control of state-dependent gene expression. J Neurosci 2004;24(23):5410-5419.
40. Petty F, Kramer G,Wilson L, Chae Y-L. Learned helplessness and in vivo hippocampal norepinephrine release. Pharmacol Biochem Behav 1993;46:231-235.
41. Seligman EP, David L, Rosenhan. Depression and suicide. In: Abnormality.WW Norton and Company Inc; 1998:246.
42. Bloom FE, Lazerson A. Emotions: The highs and the lows of the brain. In Brain, Mind and Behaviour. 2nd edition. NY: Freeman and Company; 1996:231.
43. Barret JA, Shaikh MB, Edinger H, Siegel A. The effects of intrahypothalamic injections of norepinephrine upon affective defense behaviour in the cat. Brain Res 1987;426:381-384.
44. Rasmussen K, Jacobs BL. Single-unit activity of locus coeruleus neurons in the freely moving cat II. Conditioning and pharmacological studies. Brain Res 1986;371:335-344.
45. Rasmussen K, Morilak DA, Jacobs BL. Single-unit activity of locus coeruleus neurons in the freely moving cat I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986;371:324.
46. Levine ES, Litto WJ, Jacobs BL. Activity of cat locus coeruleus noradrenergic neurons during the defense reaction. Brain Res 1990;531:189-195.
47. Grant SJ, Redmond DE. Neuronal activity of the locus coeruleus in awake Macaca arctoides. Exp Neurol 1984;84:701-708.
48. Redmond DE jr. New and old evidence for the involvement of a brain norepinephrine system in anxiety. In: Phenomenology and Treatment of Anxiety. Spectrum Pub;1979. pp 153-201.
49. Redmond D, Huang Y. New evidence for a locus coeruleus norepinephrine connection with anxiety. Life Sci 1979;25:2149-2162.
50. Abercrombie ED, Jacobs BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats II. Adaptation to chronically presented stressful stimuli. J Neurosci 1987;7:2844-2848.
51. Aghajanian G. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 1978; 276:186-188.
52. Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats is a function of sensory stimulation and arousal. Proc Natl Acad Sci 1980;USA, 77:3033-3037.
53. Aston-Jones G. Behavioural function of locus coeruleus derived from cellular attributes. Physiol Psychol 1986;13:118-126.
54. Rosenzweig MR, Leiman AL, Breedlove SM. Biological rhythms, sleep and dreaming. In: Biological Psychology. Massachusetts: Sinauer Ass Inc; 1999. 300-406.
55. Bloom FE, Lazerson A. Emotions: The highs and the lows of the brain. In: Brain, Mind and Behaviour. NY: WH Freeman & company; 1996:208-237.
56. Bloom FE, Lazerson A. Homeostasis: Maintaining the internal environment. In: Brain Mind and Behaviour. NY:WH Freeman and Company; 1996:399.
57. Le Doux J. Once more with feeling. In: The Emotional Brain. London: Phoenix Paperback, 1999:267-303.
58. Donovan BT. Humors, Hormones and the Mind. An approach to the understanding of behaviour. London: MacMillan Press,1988:159-208.
59. Arnsten AF. Catecholamine regulation of the prefrontal cortex. J Psychopharm 1997;11(2):151-162.
60. Sakanaka M, Shibasaki T, Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in rat amygdaloid complex. Brain Res 1986;382:213-238.
61. Bloom FE, Lazerson A. Learning and memory. In: Brain, Mind and Behavior. NY: WH Freeman and Company; 1996:261.
62. Kopin IJ, Eisenhofer G, Goldstein D. In: Chrousos GP, Loriaux DL, Gold PW, editors. Mechanisms of physical and emotional stress. NY and London. Plenum Press; 1988:11-23.
63. Gabel S, Stadler J, Bjorn J, Shindledecker R, Bowden CL. Sensation seeking in psychiatrically disturbed youth: relationship to biochemical parameters and behavior problems. J Am Acad Child Adol Psychiatry 1994;33(1):123-129.
64. Garvey MJ, Noyes R jr, Cook B, Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Res 1996;65(1):61-64.
65. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gamling. Psychol Med 1997;27(2):473-475.
66. Gabel S, Stadler J, Bjorn J, Shindledecker R. Homovanillic acid and dopamine-beta-hydroxylase in male youth: relationships with paternal substance abuse and antisocial behavior. Am J Drug Alcohol Abuse 1995;21(3):363-378.
67. De Witte P. The role of neurotransmitters in alcohol dependence: animal research. Alcohol 1996;319 (Suppl)1:13-16.
68. Clayton CJ, Hicks RE. Ethanol, monoamines, and affect. J Neur Transm Gen Sect 1994;98(3):169-195.
69. Kaplan HI, Sadock BJ, Grebb JA. Synopsis of Psychiatry 7th edition. Behavioural Sciences. Clinical Psychiatry. Baltimore: Maryland, Williams and Wilkins, 1994.
70. Kavoussi R, Armstead P, Coccaro E. The neurobiology of impulsive aggression. Psychiatr Clin North Am 1997;20(2):395-403.
71. Williams RB jr, Suarez EC, Kuhn CM, Zimmerman EA, Schanberg SM. Biobehavioural basis of coronary-prone behavior in middle men. Part 1: Evidence for chronic SNS activation in Type A. Psychosom Med 1991;53:517-527.
72. Figueroa E, Silk KR. Biological implications of childhood sexual abuse in borderline personality disorder. J Pers Dis 1997;11(1): 71-92.
73. Arango V, Underwood MD, Mann JJ. Biological alterations in the brainstem of suicides. Psychiatr Clin North Am 1997;20(3):581-593.
74. Gilbert C. Major human cancers are preventable: psychological stimuli induce a dopamine-thyroid - immune efficient mechanism. Psychiatr Clin North Am 1997;20(3):581-593.
75. Pirke KM. Central and peripheral noradrenaline regulation in eating disorders. Psychiatry Res 1996;62(1):43-49.
76. McElroy SL, Pope HG jr, Keck PE jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996;37(4):229-240.
77. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 1996;35(3):264-272.
78. Kafka MP. A monoamine hypothesis for the pathophysiology of paraphillic disorders. Arch Sex Behav 1997;26(4):343-358.
79. Krystal JH, Deutsch DN. Charney DS. The biological basis of panic disorder. J Clin Psychiatry 1996;57((Suppl)10:23-31.
80. Brawman-Mintzer O, Lydiard RB. Biological basis of generalized anxiety disorder. J Clin Psychiatry 1997;58(Suppl)3:16-25.
81. Southwick SM, Krystal JH, Bremner JD. Morgan CA, Nicolaou AL, Nagy LM, et al. Noradrenergic and serotonergic function in post-traumatic stress disorder. Arch Gen Psychiatry 1997;54(8):749-758.
82. Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 1997;58(Suppl)2:4-11.
83. Meas M, Minner E, Suy C, Vandervorst, Raus J. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia. J Neural Transm 1991;85:195-210.
84. Fritze J. The adrenergic-cholinergic imbalance hypothesis of depression: A review and a perspective. Rev Neurosci 1993; 4(1):63-93.
85. Sulser F, Sanders-Bush E. The serotonin-norepinephrine link hypothesis of affective disorders: Receptor-receptor interactions in brain. Adv Exp Med Biol 1987;221:489-572.
86. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psych 1994;51(5):411-22.
87. Potter WZ, Manji HK. Catecholamines in depression: An Update. Clin Chem 1994;40(2):279-287.
88. Maas JW, Katz MM, Koslow SH, Swann A, Davis JM, Berman N, Bowden CL, Stokes PE, Landis H. Adrenomedullary function in depressed patients. J Psych Res 1994;28(4):357-367.
89. Dinan TG. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction? J Clin Psychiatry 1996;57(Suppl 4):14-18.
90. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 1997;17(21):8451-8458.
91. Mokrani MC, Duval F, Crocq MA, Bailey P, Macher JP. HPA axis dysfunction in depression: Correlation with monoamine system abnormalities. Psychoneuroendocrinol 1997;22 (Suppl)1:S63-68.
92. Kelly CB, Cooper SJ. Plasma noradrenaline reponse to electroconvulsive therapy in depressive illness. Br J Psychiatry 1997;171:182-186.
93. Carlsson A, Hansson LO, Waters N, Carlsson ML. Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications. Life Sci 1997;61(2):75-94.
94. Palmer AM. Neurochemical studies of Alzheimer's disease. Neurodegeneration 1996;5(4):381-91.
95. Schwartz JP. Development and plasticity. Overview. Adv Pharmacol 1998;42:877-882.
96. Marshall KC, Christie MJ, Finlayson PG,Williams LT. Developmental aspects of the locus coeruleus noradrenaline system. Prog Brain Res 1991;88:173-185.
97. Boyeson MG, Krobert KA. Cerebellar norepinhephrine infusions, facilitate recovery after sensorimotor cortex injury. Brain Res Bull 1992;29:435-439.
98. Vaccarino FM, Hayward MD, Lee MW, Harigan DJ, Duman RS, Nestler EJ. Induction of immediate early genes by c-AMP in primary cultures of neurons from rat cerebral cortex. Molec Brain Res 1993;19:76-82.
99. Bryan RMJ jr. Cerebral blood flow and energy metabolism during stress. Am J Physiol 1990;259:H269-H280.
100. Bryan RM, Lehmann RAW. Cerebral glucose utilization after aversive conditioning and during conditioned fear in rat. Brain Res 1988;444:17-24.
101. Stone AA, Ariano MA. Are glial cells targets of the cerebral adrenergic systems? Brain Res Rev 1989;14:297-308.
102. Nathanson JA. Adrenergic receptors in brain microvessels. Trends Neurol Sci 1983;4:422-424.
103. Ohata M, Takei HO, Fredericks WR, Rapoport SJ. Effects of immobilization stress on cerebral blood flow and cerebrovascular permeability in spontaneously hypertensive rats. J Cereb Blood Flow Metab 1982;2:373-379.